세계의 유전자 독성 검사 시장 보고서(2025년)
Genetic Toxicology Testing Global Market Report 2025
상품코드 : 1825745
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

유전자 독성 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.2%로 25억 6,000만 달러로 성장할 것입니다. 예측 기간의 성장은 새로운 식품에 대한 시험 수요 증가, 잠재적 위험에 대한 우려 증가, 환경 및 건강에 대한 관심 증가, 규제 당국의 감시 강화, in vitro 시험법 사용 증가, 하이스루풋 스크리닝 플랫폼의 부상 등에 기인할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 정밀의료와 독성유전체학의 발전, 종합적인 리스크 커뮤니케이션, 유전자 독성 검사 방법, 리스크 평가 방법의 발전, 오믹스 기술의 통합, 유전체학 및 분자생물학의 발전 등이 있습니다.

향후 5년간 9.2%의 성장률 전망은 지난번 전망치보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 일본에서 조달하는 암스 테스트 키트와 염색체 이상 측정 시약의 비용을 상승시켜 미국을 저해하고, 의약품의 안전성 평가를 지연시키며, 의약품 개발 비용을 상승시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

맞춤형 의료에 대한 수요의 급증은 향후 몇 년간 유전자 독성 검사 시장의 확대를 견인할 것으로 예상됩니다. 개인맞춤의료는 예측된 반응과 질병 위험에 따라 환자 개개인에게 맞춤화된 개입과 제품을 제공하는 의료 접근법으로, 유전학적 발전, 질병에 대한 이해의 향상, 바이오마커 기반 진단의 가용성, 가치 기반 의료에 대한 노력, 임상 진료 및 연구와의 통합을 통해 지지를 받고 있습니다. 지지를 모으고 있습니다. 유전독성 검사는 유전자의 다양성, 유전독성 물질에 대한 감수성, 치료 반응에 대한 중요한 인사이트를 제공함으로써 맞춤의료에서 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월 개인맞춤의료연합(Personalized Medicine Coalition)이 보고한 바와 같이, FDA는 2023년 희귀질환 환자를 위한 16개의 맞춤형 신약을 승인했으며, 이는 2022년 6개에서 크게 증가한 수치입니다. 이처럼 맞춤형 의료에 대한 수요 증가는 유전자 독성 검사 시장의 촉매제 역할을 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Genetic toxicology testing is a specialized field within toxicology dedicated to assessing the potential of chemical substances to cause damage to genetic material, including DNA, RNA, and chromosomes. Its primary objective is to determine the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. This testing serves as a crucial tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants, particularly concerning genotoxic hazards.

The primary classifications within the genetic toxicology testing market include in vitro and in vivo methodologies. In vitro testing refers to experiments or studies conducted in a controlled laboratory environment, such as test tubes, petri dishes, or other artificial settings, without the involvement of living organisms. Various products encompass services, reagents, consumables, and assays, utilized across diverse applications spanning the healthcare, food, cosmetics, agriculture industries, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genetic toxicology testing market research report is one of a series of new reports from The Business Research Company that provides genetic toxicology testing market statistics, including the genetic toxicology testing industry's global market size, regional shares, competitors with a genetic toxicology testing market share, detailed genetic toxicology testing market segments, market trends, and opportunities, and any further data you may need to thrive in the genetic toxicology testing industry. This genetic toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genetic toxicology testing market size has grown rapidly in recent years. It will grow from $1.63 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to rising public health crises, increasing globalization, increased focus on personalized medicine, rising demand for rigorous testing solutions, and an increasing number of drugs.

The genetic toxicology testing market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising demand for testing novel foods, rising concerns about potential risks, rising environmental and health concerns, increasing regulatory scrutiny, increasing use of in vitro testing methods, and the rise of high-throughput screening platforms. Major trends in the forecast period include advances in precision medicine and toxicogenomic, comprehensive risk communication, genetic toxicology testing methodologies, advancing risk assessment methodologies, integration of omics technologies, and advancements in genomics and molecular biology.

The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Ames test kits and chromosomal aberration assay reagents sourced from Germany and Japan, thereby delaying drug safety evaluations and elevating pharmaceutical development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in demand for personalized medicine is anticipated to drive the expansion of the genetic toxicology testing market in the coming years. Personalized medicine, a healthcare approach that tailors interventions and products to individual patients based on their predicted response or disease risk, has gained traction due to genetic advancements, improved disease understanding, biomarker-based diagnostics availability, value-based healthcare initiatives, and integration into clinical practice and research. Genetic toxicology testing plays a vital role in personalized medicine by furnishing crucial insights into genetic variability, susceptibility to genotoxic agents, and treatment response. For instance, as reported by the Personalized Medicine Coalition in February 2024, the FDA greenlit 16 new personalized medicines for rare disease patients in 2023, a significant increase from six in 2022. Thus, the growing demand for personalized medicine serves as a catalyst for the genetic toxicology testing market.

Major players in the genetic toxicology testing market are concentrating on developing innovative drug screening platforms such as phenotypic drug screening to enhance accuracy and efficiency in identifying potential genetic toxins. Phenotypic drug screening involves testing compounds based on their capacity to elicit a specific cellular or physiological response in a whole organism or relevant cell system. For example, in August 2022, Creative Biogene, a US-based biotechnology company, unveiled zebrafish disease models tailored to support drug discovery and toxicology research. These models replicate human genetic diseases in zebrafish, offering insights into disease mechanisms, drug discovery, and toxicology. Creative Biogene's zebrafish models serve as a valuable tool for evaluating drug toxicity, predicting the safety of novel compounds, and bolstering the drug development pipeline.

In September 2024, Scantox Group, a Denmark-based contract research organization, acquired Gentronix for an undisclosed amount. This acquisition enables Scantox to enhance its portfolio by incorporating Gentronix's expertise in genetic toxicology testing. Gentronix Ltd., a UK-based company, specializes in providing accurate genetic toxicology testing services.

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories.

North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genetic toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genetic toxicology testing market includes revenues earned by entities through mutagenicity testing, genotoxicity screening, carcinogenicity testing, regulatory compliance, risk assessment, bacterial mutation assays, comet assays, micronucleus tests, presymptomatic testing, ancestry testing, and nutrigenomics testing, and related cell culture systems, assay kits, microscopes, flow cytometers, automation and robotics, and flow cytometry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genetic toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genetic toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Genetic Toxicology Testing Market Characteristics

3. Genetic Toxicology Testing Market Trends And Strategies

4. Genetic Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genetic Toxicology Testing Growth Analysis And Strategic Analysis Framework

6. Genetic Toxicology Testing Market Segmentation

7. Genetic Toxicology Testing Market Regional And Country Analysis

8. Asia-Pacific Genetic Toxicology Testing Market

9. China Genetic Toxicology Testing Market

10. India Genetic Toxicology Testing Market

11. Japan Genetic Toxicology Testing Market

12. Australia Genetic Toxicology Testing Market

13. Indonesia Genetic Toxicology Testing Market

14. South Korea Genetic Toxicology Testing Market

15. Western Europe Genetic Toxicology Testing Market

16. UK Genetic Toxicology Testing Market

17. Germany Genetic Toxicology Testing Market

18. France Genetic Toxicology Testing Market

19. Italy Genetic Toxicology Testing Market

20. Spain Genetic Toxicology Testing Market

21. Eastern Europe Genetic Toxicology Testing Market

22. Russia Genetic Toxicology Testing Market

23. North America Genetic Toxicology Testing Market

24. USA Genetic Toxicology Testing Market

25. Canada Genetic Toxicology Testing Market

26. South America Genetic Toxicology Testing Market

27. Brazil Genetic Toxicology Testing Market

28. Middle East Genetic Toxicology Testing Market

29. Africa Genetic Toxicology Testing Market

30. Genetic Toxicology Testing Market Competitive Landscape And Company Profiles

31. Genetic Toxicology Testing Market Other Major And Innovative Companies

32. Global Genetic Toxicology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genetic Toxicology Testing Market

34. Recent Developments In The Genetic Toxicology Testing Market

35. Genetic Toxicology Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기